Development of central 5-HT2A receptor radioligands for PET: Comparison of [3H]RP 62203 and [3H]SR 46349B kinetics in rat brain

Nuclear Medicine and Biology

Volumn 23, Issue 3, 1996, Pages 245-250

  Ashworth, Sharon ^a   Hume, Susan P ^a   Lammertsma, Adriaan A ^a   Opacka Juffry, Jolanta ^a   Shah, Farah ^a   Pike, Victor W ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

5 HT2A; PET; Receptor studies; 3H RP 62203; 3H SR 46349B

Indexed keywords

EPLIVANSERIN; FANANSERIN; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; RAT;

ANIMALS; BRAIN; CYCLIC S-OXIDES; FLUOROBENZENES; KINETICS; MALE; MODELS, THEORETICAL; NAPHTHALENES; PHENOLS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SUBSTRATE SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; TRITIUM;

EID: 0030009963     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(95)02053-5     Document Type: Article

References (35)

1. 2) receptor binding in the frontal cortex of schizophrenic patients. J. Neural Transm.[Gen. Sect.] 85, 19-29.
2. 2 receptors in humans using positron emission tomography. Eur. J. Nucl. Med. 21, 937-946.
3. 2 receptors in Alzheimer's disease. Brain. 116, 497-510.
4. 18F-setoperone. J. Cereb. Blood Flow Metab. 11 (Suppl. 2), S188.
5. 18F-labeled setoperone. J. Neurochem. 54, 1744-1754.
6. Bowen D.M., Najlerahim A., Procter A. W., Francis P. T. and Murphy E. (1989) Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Proc. Natl Acad. Sci. USA 86, 9504-9508.
7. 2 antagonist). J. Chem. Soc. Perkin. Trans. I., 3185.
8. Crouzel C., Guillaume M., Barré L., Lemaire C. and Pike V. W. (1992) Ligands and tracers for PET studies of the 5HT system - current status. Nucl. Med. Biol. 19, 857-870.
9. 2A receptors. J. Label. Compd. Radiopharm. 35, 497-499.
10. D'haenen H., Bossuyt A., Mertens J., Bossuyt-Piron C., Gijsemans M. and Kaufman L. (1992) SPECT imaging of serotonin2 receptors in depression. Psychiatry Res. 45(4), 227-237.
11. 2 receptor antagonist. Br. J. Pharmacol. 105, 27-36.
12. 2/1C antagonist, and negative symptoms in schizophrenia. Br. J. Psychiatry. 163, 451-455.
13. 2 receptors. Eur. J. Pharmacol. 216, 53-57.
14. Frost J. J. (1990) Imaging the serotonergic system by positron emission tomography. Ann. NY Acad. Sci. 600, 272-281.
15. 2 receptor antagonist, RP 62203, selectively blocks serotoninergic but not dopaminergic-induced inhibition in the rat prefrontal cortex. Eur. J. Pharmacol. 204, 97-100.
16. Hoyer D., Clark D. E., Fozard J. R., Hartig P. R., Martin G. R., Myecharare E. J., Saxena P. R. and Humphrey P. A. (1994) VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 46, 157-203.
17. 1-adrenergic receptors in human brain cortex. J. Cardiovascular Pharmacol. 10 (Suppl. 3), S48-S50.
18. 2 receptors in rat brain: An autoradiographic study. Synapse 14, 324-331.
19. 11C]citalopram as a radioligand for in vivo labelling of 5-hydroxytryptamine uptake sites. Nucl. Med. Biol. 19 (8), 851-855.
20. 11C]raclopride studies. J. Cereb. Blood Flow Metab. 16, 42-52.
21. 2) by rapid "in situ" piperazine formation. Appl. Radiat. Isot. 45, 1085-1092.
22. 2 receptors for positron emission tomography studies. J. Label. Compd. Radiopharm. 35, 441-443.
23. Lemaire C., Cantineau R., Guillaume M., Plenevaux A. and Christiaens L. (1991) Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. J. Nucl. Med. 32, 2266-2272.
24. Levy A. D. and Van de Kar L. D. (1992) Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants. Life Sci. 51, 83-94.
25. 2A receptor antagonist. In vitro and ex vivo selectivity profile. Eur. J. Pharmacol. 233, 29-35.
26. 3H]RP 62203 binding in the rat brain. Eur. J. Pharmacol. 233, 37-45.
27. 2 antagonists. J. Med Chem. 34, 2477-2483.
28. Pazos A., Cortés R. and Palacios J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the tat brain. II. Serotonin-2 receptors. Brain Res. 346, 231-249.
29. Pazos A., Probst A. and Palacios J. M. (1987) Serotonin receptors in the human brain - IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21(1), 123-139.
30. Peroutka S. J. (1993) 5-Hydroxytryptamine receptors. J. Neurochem. 60, 408-416.
31. 2 receptor antagonist, in rodent brain. Life Sci. 54, 119-127.
32. Rinaldi-Carmona M., Congy C., Santucci V., Simiand J., Gautret B., Neliat G., Labeeuw B., Le Fur G., Soubrie P. and Breliere J. C. (1992) Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine, receptor antagonist. J. Pharmacol. Exp. Ther. 262, 759-768.
33. Tan P., Dewey S. L., Gatley S. J., Pappas N., MacGregor R., Ding Y. S., Shea C., Alexoff D., Martin T., Jenkins D., King P., Fowler J. S., Ashby C. and Wolf A. (1994) Drug pharmacokinetics and pharmacodynamics: PET and microdialysis studies of SR 46349B, a selective 5HT2 antagonist. J. Nucl. Med. 35, 67P.
34. 2 receptor changes in major depression. Biol. Psychiatry. 27, 489-496.
35. 11C]-Methyl)-2-Br-LSD. Synapse. 1, 393-398.